Peptic Ulcer Testing: A Global Strategic Business Report
San Jose, CA (PRWEB) March 23, 2010
Peptic ulcer, the most commonly occurring stomach disease, is caused by sores and lesions formed due to excess secretion of hydrochloric acid and pepsin enzyme from histamine cells into the gastrointestinal tract. The disease commonly occurs due to the Helicobacter pylori (H. pylori) bacterium, but might also be caused by long-term use of non-steroidal anti-inflammatory drugs, and in rare instances due to inheritance or presence of some specific illness. Although only 10-15% of H. pylori positive cases develop peptic ulcers, up to 90% of all peptic ulcers occur due to H. pylori.
Asia-Pacific is the largest market for rapid tests for H. pylori in the world, as stated by the new market research report on peptic ulcer testing. The incidence of peptic ulcer disease is quite high in Asia-Pacific region, with 70-80% of the population estimated to be H. pylori positive. Most countries in this region are under-developed or developing and have relatively poor sanitation and hygienic conditions, which gives rise to contracting H. pylori infections.
Latin America has the highest prevalence of H. pylori infection in the world where between 80 and 90% of the population is H. pylori positive. However, since not all H. pylori infections lead to the development of peptic ulcers, the pool of peptic ulcer patients is relatively smaller in the region.
Blood tests or Serology tests are relatively cheaper, which partly explains the popularity of these tests in H. pylori detection. Other popular tests include Tissue tests,
Urea Breath Tests, and Stool Antigen tests. Medical reimbursement of certain tests for H. pylori is a factor that affects its availability in a particular country. Diagnostic tests such as urease tests, though simple and easy to perform, are plagued with reimbursement issues in some countries. Other tests such as stool antigen ELISA tests are marred with cost issues.
Key players profiled in the report include Beckman Coulter Inc., Biomerica Inc., Kibion AB, Meretek Diagnostics Group of Otsuka America Pharmaceutical Inc., Meridian Bioscience Inc., Orion Diagnostica Oy, and Quidel Corp., among others.
The report titled "Peptic Ulcer Testing: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a strategic review of the peptic ulcer disease, peptic ulcer testing market, the various types of tests available such as serology tests, tissue tests (histology, Urease, and Culture), urea breath tests and stool antigen tests, and also corporate initiatives of select participants over recent years. The study analyzes market data and analytics in terms of dollar revenue for regions including The United States, Japan, Europe, Asia-Pacific, Latin America and Rest of World.
For more details about this comprehensive market research report, please visit - http://www.strategyr.com/Peptic_Ulcer_Testing_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com/